FAVOURABLE OUTCOME of IN VITRO SELECTIONS WITH NOVEL NRTI PRODRUG GS-9131
Reported by Jules Levin
CROI 2019 March 4-7 Seattle
Ruxandra-Ilinca Ibanescu1, Maureen Oliviera1, Bonnie Spira1, Jean-Pierre Routy2, Bluma G. Brenner2 and Montreal Primary HIV (PHI) Cohort Study Group.
1Lady Davis Institute for Medical Research, Montreal, QC, Canada, 2McGill University, Montreal, QC, Canada
